Cargando…
Vasculotide reduces endothelial permeability and tumor cell extravasation in the absence of binding to or agonistic activation of Tie2
Angiopoietin-1 (Ang1) activation of Tie2 receptors on endothelial cells (ECs) reduces adhesion by tumor cells (TCs) and limits junctional permeability to TC diapedesis. We hypothesized that systemic therapy with Vasculotide (VT)—a purported Ang1 mimetic, Tie2 agonist—can reduce the extravasation of...
Autores principales: | Wu, Florence TH, Lee, Christina R, Bogdanovic, Elena, Prodeus, Aaron, Gariépy, Jean, Kerbel, Robert S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459817/ https://www.ncbi.nlm.nih.gov/pubmed/25851538 http://dx.doi.org/10.15252/emmm.201404193 |
Ejemplares similares
-
Adjunctive therapy with the Tie2 agonist Vasculotide reduces pulmonary permeability in Streptococcus pneumoniae infected and mechanically ventilated mice
por: Lask, Aina, et al.
Publicado: (2022) -
The Tie2-agonist Vasculotide rescues mice from influenza virus infection
por: Sugiyama, Michael G., et al.
Publicado: (2015) -
The synthetic Tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis
por: Kümpers, Philipp, et al.
Publicado: (2011) -
The Synthetic Tie2 Agonist Peptide Vasculotide Protects Renal Vascular Barrier Function In Experimental Acute Kidney Injury
por: Rübig, Eva, et al.
Publicado: (2016) -
A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis
por: Khan, Kabir A, et al.
Publicado: (2020)